Evidence map›Paper›PMID 36583253›Full record

ReviewJournal of global health2022

Characterization of COVID-19 cases in the early phase (March to July 2020) of the pandemic in Kenya.

Philip Ngere, Joyce Onsongo, Daniel Langat, Elizabeth Nzioka, Faith Mudachi, Samuel Kadivane, Bernard Chege, Elvis Kirui, Ian Were, Stephen Mutiso and 18 more

Abstract readCase ReportsReview
In one paragraph

Review in Journal of global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Philip NgereDepartment of Disease Surveillance and Epidemic Response, Ministry of Health, Kenya.
Joyce OnsongoWorld Health Organization, Nairobi Kenya.
Daniel LangatDepartment of Disease Surveillance and Epidemic Response, Ministry of Health, Kenya.
Elizabeth NziokaPublic Health Emergency Operation Centre, Ministry of Health, Kenya.
Faith MudachiDepartment of Promotive and Preventive Health, Ministry of Health, Kenya.
Samuel KadivaneDepartment of Disease Surveillance and Epidemic Response, Ministry of Health, Kenya.
Bernard ChegePublic Health Emergency Operation Centre, Ministry of Health, Kenya.
Elvis KiruiNational Public Health Laboratory Services, Ministry of Health, Kenya.
Ian WereOffice of the Director General, Ministry of Health, Kenya.
Stephen MutisoDepartment of Promotive and Preventive Health, Ministry of Health, Kenya.
Amos KibisuPublic Health Emergency Operation Centre, Ministry of Health, Kenya.
Josephine IhahiPublic Health Emergency Operation Centre, Ministry of Health, Kenya.
Gladys MutethyaPublic Health Emergency Operation Centre, Ministry of Health, Kenya.
Trufosa MochacheWorld Health Organization, Nairobi Kenya.
Peter LokamarNational Public Health Laboratory Services, Ministry of Health, Kenya.
Waqo BoruField Epidemiology and Laboratory Training Program, Ministry of Health, Kenya.
Lyndah MakayottoDepartment of Disease Surveillance and Epidemic Response, Ministry of Health, Kenya.
Emmanuel OkungaDepartment of Disease Surveillance and Epidemic Response, Ministry of Health, Kenya.
Nollascus GandaWorld Health Organization, Nairobi Kenya.
Adam HajiWorld Health Organization, Nairobi Kenya.
Carolyne GathenjiWorld Health Organization, Nairobi Kenya.
Winfred KariukiWorld Health Organization, Nairobi Kenya.
Eric OsoroWashington State University, Global Health, Kenya.
Kadondi KaseraPublic Health Emergency Operation Centre, Ministry of Health, Kenya.
Francis KuriaDirectorate of Public Health, Ministry of Health, Kenya.
Rashid AmanCabinet Administrative Secretary, Ministry of Health, Kenya.
Juliet NabyongaWorld Health Organization, Nairobi Kenya.
Patrick AmothOffice of the Director General, Ministry of Health, Kenya.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: Kenya detected the first case of COVID-19 on March 13, 2020, and as of July 30, 2020, 17 975 cases with 285 deaths (case fatality rate (CFR) = 1.6%) had been reported. This study described the cases during the early phase of the pandemic to provide information for monitoring and response planning in the local context. Methods: We reviewed COVID-19 case records from isolation centres while considering national representation and the WHO sampling guideline for clinical characterization of the COVID-19 pandemic within a country. Socio-demographic, clinical, and exposure data were summarized using median and mean for continuous variables and proportions for categorical variables. We assigned exposure variables to socio-demographics, exposure, and contact data, while the clinical spectrum was assigned outcome variables and their associations were assessed. Results: A total of 2796 case records were reviewed including 2049 (73.3%) male, 852 (30.5%) aged 30-39 years, 2730 (97.6%) Kenyans, 636 (22.7%) transporters, and 743 (26.6%) residents of Nairobi City County. Up to 609 (21.8%) cases had underlying medical conditions, including hypertension (n = 285 (46.8%)), diabetes (n = 211 (34.6%)), and multiple conditions (n = 129 (21.2%)). Out of 1893 (67.7%) cases with likely sources of exposure, 601 (31.8%) were due to international travel. There were 2340 contacts listed for 577 (20.6%) cases, with 632 contacts (27.0%) being traced. The odds of developing COVID-19 symptoms were higher among case who were aged above 60 years (odds ratio (OR) = 1.99, P = 0.007) or had underlying conditions (OR = 2.73, P < 0.001) and lower among transport sector employees (OR = 0.31, P < 0.001). The odds of developing severe COVID-19 disease were higher among cases who had underlying medical conditions (OR = 1.56, P < 0.001) and lower among cases exposed through community gatherings (OR = 0.27, P < 0.001). The odds of survival of cases from COVID-19 disease were higher among transport sector employees (OR = 3.35, P = 0.004); but lower among cases who were aged ≥60 years (OR = 0.58, P = 0.034) and those with underlying conditions (OR = 0.58, P = 0.025). Conclusion: The early phase of the COVID-19 pandemic demonstrated a need to target the elderly and comorbid cases with prevention and control strategies while closely monitoring asymptomatic cases.

Indexed as

COVID-19AgedComorbidityFemaleHumansKenyaMalePandemicsSARS-CoV-2

Identifiers

PMID36583253
PMCPMC9801068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.